INSIGHTS ON DRUG DEVELOPMENT
-
Spray Dried Biologics For Pulmonary Dosage Forms
View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.
-
Accelerated Yield Optimization Of Affinity Capture
High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.
-
Working With Clients To Develop Manufacturing Processes
Greg Buenger, Group Leader of Chemical Development at Cambrex Charles City, on what it actually looks like when R&D hands a process to the plant — chemists on the floor for the first batch, advising operators and troubleshooting in real time.
-
Addressing Raw Material Handling Challenges By Dry Granulation
Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.
-
Accelerate FDA Approval With Fast Track Designation7/3/2025
Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
Solving Bioavailability Challenges In bRo5 Drugs3/20/2026
Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.
-
The Complete Flow Cytometry Guide9/24/2024
This guide covers the fundamentals of flow cytometry, aiming to help you better understand how it works, when it is most valuable, and how to conduct an experiment.
-
Biocatalysis 101: Faster, Greener API Manufacturing4/20/2026
View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.
-
Scaling Up Your E. Coli pDNA Process From Parameter Screening To Pilot Scale6/26/2025
Discover a systematic approach to scalable plasmid DNA production using E. coli OneShot Top10, which features DOE-driven optimization and key insights for efficient biomanufacturing success.
DRUG DEVELOPMENT SOLUTIONS
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.
-
Observe the viability of your cells with the field-upgradeable cellular imaging option for the SpectraMax i3/i3x Multi-mode Detection Platform.
-
Re-engineer your drug's path into clinical development and accelerate time to Proof-of-Concept. Real-time data guides rapid formulation iterations, minimizing drug substance use and lowering program risk.
-
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.